Renaissancere Holdings Ltd
NYSE:RNR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Renaissancere Holdings Ltd
NYSE:RNR
|
BM |
|
N
|
Novo Nordisk A/S
OTC:NONOF
|
DK |
|
J
|
Jobubu Jarum Minahasa PT Tbk
IDX:BEER
|
ID |
|
M
|
Medibank Private Ltd
F:MPV
|
AU |
|
Hysan Development Co Ltd
F:HYN
|
HK |
|
Lords & Company Worldwide Holdings Inc
F:4XM
|
CA |
Intrinsic Value
Is RNR undervalued or overvalued?
See the intrinsic value estimate for Renaissancere Holdings Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
RNR looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with RNR’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Renaissancere Does
RenaissanceRe Holdings Ltd. is a specialty reinsurer. It does not sell insurance directly to most consumers; instead, it sells protection to insurance companies and other clients that want to pass along large or hard-to-predict risks, especially property catastrophe losses from events like hurricanes and earthquakes. It also writes some specialty insurance and reinsurance business outside the catastrophe market.
- Headquarters
- Bermuda BM
- Employees
- 1 040
- IPO date
- Jul 24, 1996
Renaissancere Holdings has no economic moat
Insurers can shop their reinsurance needs among traditional reinsurers and alternative providers, which compete on price and contract terms. RenaissanceRe’s expertise and customer relationships may help it win business, but there is no clear evidence that customers are locked in or that rivals are kept out.
Read the full moat analysis
The intrinsic value for Renaissancere Holdings Ltd (RNR) under the Base Case is hidden USD.
Compared with the current market price of 339.78 USD, the stock appears hidden.